EarningsQ2 2025 Earnings Report

Crescent Biopharma (C68) Q2 2025 Earnings Report

2 Followers

DE:C68 Q2 2025 EPS Results

Actual EPS-€4.22

Consensus EPS-€1.43

Beat/MissMissed by -€2.80

One Year Ago EPS-€13.42

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2025

Date07/31/2025

TimeBefore Open

Conference CallThursday, July 31, 2025

DE:C68 Upcoming Earnings

Crescent Biopharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.58 / -	-1.088	―
Jul 30, 2026	2026 (Q2)	-0.63 / -0.63	-4.225	84.99% (+3.59)
Apr 29, 2026	2026 (Q1)	-0.75 / -0.60	-15.27	96.07% (+14.67)
Feb 26, 2026	2025 (Q4)	-2.12 / -3.44	-6.855	49.88% (+3.42)
Nov 06, 2025	2025 (Q3)	-1.68 / -1.09	-308.796	99.65% (+307.71)
Jul 31, 2025	2025 (Q2)	-1.43 / -4.22	-13.416	68.51% (+9.19)
May 01, 2025	2025 (Q1)	-0.04 / -0.04	-0.146	70.59% (+0.10)
Feb 27, 2025	2024 (Q4)	-0.07 / -0.10	-0.12	20.00% (+0.02)
Nov 07, 2024	2024 (Q3)	-0.09 / -0.13	-0.12	-8.57% (-0.01)
Aug 01, 2024	2024 (Q2)	-0.15 / -0.14	-0.111	-26.92% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed